Literature DB >> 27474692

Response to proposed research to reverse brain death: more than regulatory failure.

Sandhya Srinivasan1, Veena Johari2.   

Abstract

In early May 2016, reports of a bizarre study to attempt a reversal of brain death made the headlines, but there was not even a squeak from the authorities. The "Reanima Project" is a collaboration between an Indian surgeon, Himanshu Bansal, and a US-based biotech company, Bioquark Inc. The research will be conducted by Bansal's own biotech company, Revita Life Sciences, at his Anupam hospital in Rudrapur, a city in Uttarakhand state.

Entities:  

Mesh:

Year:  2016        PMID: 27474692     DOI: 10.20529/IJME.2016.039

Source DB:  PubMed          Journal:  Indian J Med Ethics        ISSN: 0974-8466


  1 in total

1.  Response to a trial on reversal of Death by Neurologic Criteria.

Authors:  Ariane Lewis; Arthur Caplan
Journal:  Crit Care       Date:  2016-11-22       Impact factor: 9.097

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.